活产新生儿代谢性酸血症定义标准的比较及其对预测严重不良新生儿结局的影响
回顾性队列研究纳入2011年1月至2019年12月单胎活产分娩,按胎龄≥35周和<35周分层。≥35周队列共91,694例,按美国妇产科医师学会标准2.9%存在代谢性酸血症,与需全身低温治疗的缺氧缺血性脑病风险近100倍升高相关(相对风险92.69,95%CI 64.42-133.35)。尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准更敏感,识别更多高危新生儿。
要点
- ≥35周活产儿中,美国妇产科医师学会标准定义的代谢性酸血症与需全身低温治疗的缺氧缺血性脑病风险近100倍升高相关。
- 尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准较美国妇产科医师学会标准多诊断4.9%的代谢性酸血症,多识别16例需全身低温治疗的足月儿。
- 两种标准下,≥35周有无代谢性酸血症新生儿的1分钟和5分钟Apgar评分均值相似且令人安心(8 vs 8和9 vs 9,P<.001)。
核心结论
- 分娩时脐带血气采集识别出的代谢性酸血症婴儿发生严重不良新生儿结局的风险显著增高,包括需全身低温治疗的缺氧缺血性脑病风险近100倍升高。
- 使用更敏感的尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准定义代谢性酸血症,可识别更多≥35周胎龄、有不良新生儿结局风险的新生儿,包括需全身低温治疗的缺氧缺血性脑病。
研究设计与样本
- 本研究的 design 为回顾性队列研究,纳入2011年1月至2019年12月单胎活产分娩。
- 按出生胎龄分层(≥35周和<35周),比较有无代谢性酸血症新生儿的母亲特征、产科并发症、产时事件及不良新生儿结局。
- 代谢性酸血症基于分娩时脐带血气分析,分别采用美国妇产科医师学会和尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准定义。
- 主要结局为需全身低温治疗的缺氧缺血性脑病。
- ≥35周胎龄符合纳入标准的新生儿共91,694例。
主要发现
- 按美国妇产科医师学会标准,2659例(2.9%)婴儿存在代谢性酸血症。
- 代谢性酸血症新生儿入住新生儿重症监护病房、惊厥、需呼吸支持、脓毒症和新生儿死亡的风险显著增高。
- 按美国妇产科医师学会标准定义的代谢性酸血症与≥35周胎龄新生儿需全身低温治疗的缺氧缺血性脑病风险近100倍升高相关(相对风险92.69,95%CI 64.42-133.35)。
- ≥35周胎龄新生儿中,糖尿病、妊娠期高血压疾病、过期产、第二产程延长、绒毛膜羊膜炎、阴道助产、胎盘早剥和剖宫产与代谢性酸血症相关,其中胎盘早剥的相对风险最高(相对风险9.07,95%CI 7.25-11.36)。
- <35周胎龄新生儿队列有相似发现。
关键数值与推荐
- 比较≥35周胎龄婴儿按美国妇产科医师学会标准 vs 尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准定义的代谢性酸血症,后者识别更多有严重不良新生儿结局风险的新生儿。
- 尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准较美国妇产科医师学会标准多诊断4.9%的代谢性酸血症新生儿,多识别16例需全身低温治疗的足月儿。
- 两种标准下,≥35周胎龄有无代谢性酸血症新生儿的1分钟和5分钟Apgar评分均值相似且令人安心(8 vs 8和9 vs 9,P<.001)。
- 尤尼斯·肯尼迪·施赖弗国家儿童健康与人类发展研究所标准的敏感度和特异度分别为86.7%和92.2%,美国妇产科医师学会标准分别为74.2%和97.2%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic acidemia is a known risk factor for serious adverse neonatal outcomes in both preterm and term infants. OBJECTIVE: This study aimed to evaluate the clinical significance of delivery umbilical cord gas measurements with regard to serious adverse neonatal outcomes, and to determine if distinct thresholds for defining metabolic acidemia differ in their ability to predict such adverse neonatal complications. STUDY DESIGN: This is a retrospective cohort study of singleton live-born deliveries between January 2011 and December 2019. Stratification according to gestational age at birth (≥35 and <35 weeks of gestation) was performed, and comparisons of maternal characteristics, obstetrical complications, intrapartum events, and adverse neonatal outcomes were made between neonates with metabolic acidemia and those without. Metabolic acidemia (based on delivery umbilical cord gas analyses) was defined using both American College of Obstetricians and Gynecologists and Eunice Kennedy Shriver National Institute of Child Health and Human Development criteria. The primary outcome of interest was hypoxic-ischemic encephalopathy requiring whole-body hypothermia. RESULTS: A total of 91,694 neonates born at ≥35 weeks of gestation met the inclusion criteria. By American College of Obstetricians and Gynecologists criteria, 2659 (2.9%) infants had metabolic acidemia. Neonates with metabolic acidemia were at markedly increased risk for neonatal intensive care unit admission, seizures, need for respiratory support, sepsis, and neonatal death. Metabolic acidemia by American College of Obstetricians and Gynecologists criteria was associated with an almost 100-fold increased risk of hypoxic-ischemic encephalopathy requiring whole-body hypothermia (relative risk, 92.69; 95% confidence interval, 64.42-133.35) in neonates born at ≥35 weeks of gestation. Diabetes mellitus, hypertensive disorders of pregnancy, postterm deliveries, prolonged second stages, chorioamnionitis, operative vaginal deliveries, placental abruption and cesarean deliveries were associated with metabolic acidemia in neonates born ≥ 35 weeks of gestation. The highest relative risk was in those diagnosed with placental abruption (relative risk, 9.07; 95% confidence interval, 7.25-11.36). The neonatal cohort born <35 weeks of gestation had similar findings. When comparing those infants born ≥ 35 weeks of gestation with metabolic acidemia by American College of Obstetricians and Gynecologists criteria vs Eunice Kennedy Shriver National Institute of Child Health and Human Development criteria, the Eunice Kennedy Shriver National Institute of Child Health and Human Development criteria identified more neonates at risk for serious adverse neonatal outcomes. In particular, 4.9% more neonates were diagnosed with metabolic acidemia, and 16 more term neonates were identified as requiring whole-body hypothermia. Mean 1-minute and 5-minute Apgar scores were similar and reassuring among neonates born at ≥35 weeks of gestation with and without metabolic acidemia as defined by both American College of Obstetricians and Gynecologists and Eunice Kennedy Shriver National Institute of Child Health and Human Development criteria (8 vs 8 and 9 vs 9, respectively; P<.001). Sensitivity and specificity were 86.7% and 92.2%, respectively, with the Eunice Kennedy Shriver National Institute of Child Health and Human Development criteria, and 74.2% and 97.2% with the American College of Obstetricians and Gynecologists criteria. CONCLUSION: Infants with metabolic acidemia identified on cord gas collection at delivery are at considerably greater risk of serious adverse neonatal outcomes, including an almost 100-fold increased risk of hypoxic-ischemic encephalopathy requiring whole-body hypothermia. Use of the more sensitive Eunice Kennedy Shriver National Institute of Child Health and Human Development criteria for defining metabolic acidemia identifies more neonates born at ≥35 weeks of gestation at risk for adverse neonatal outcomes, including hypoxic-ischemic encephalopathy requiring whole-body hypothermia.
引用
- Kraus AC, Saucedo AM, Byrne JJ, et al. A comparison of criteria for defining metabolic acidemia in live-born neonates and its effect on predicting serious adverse neonatal outcomes. Am J Obstet Gynecol. 2023. PMID: 36972891. doi:10.1016/j.ajog.2023.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。